(LYRA) is one of the several suitable candidates that passed through the screen. Here are the key reasons why it could be a profitable bet for "trend" investors. A solid price increase over a ...

As such, the Zacks rating upgrade for Lyra Therapeutics is essentially a positive comment on its earnings outlook that could have a favorable impact on its stock price. The change in a company's ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...